Mr. Ajay G. Piramal, Chairman, Piramal Enterprises addresses the shareholders at the 75th AGM

After years of successful transformation, the company is well on track to achieving its future plans. Mr. Piramal believes that both the emerging listed Financial Services and Pharma companies, with their balance sheet strength and uniqueness of our business models, are well-positioned to tap organic and inorganic growth opportunities and create long-term value for our stakeholders in the years to come.

Financial Services:
Over the next 5 years, the company aspires to:
o Expand our presence across 1,000 locations (with 500-600 branches) across India
o Grow retail disbursements by 40-50% (on a CAGR basis)
o Double the overall AUM from FY2022 levels
o Achieve a loan book mix moving to two-thirds Retail Loans and one-third Wholesale Loans

Pharma:
In the medium-to-long term, the company expects nearly 15% CAGR revenue growth across the businesses.
Our global footprint with a diversified revenue base, presence in attractive segments with high entry barriers, our capability to meet a wide range of customer requirements across multiple geographies and best-in-class quality track record, provides greater stability from a long-term investment perspective.

Dividend:
The Board has recommended a dividend of ₹ 33 per share, subject to the shareholders’ approval at the AGM. The total dividend pay-out would be ~₹ 788 Crores.